Hematopoietic stem cell mobilization with plerixafor is safe and effective in poorly mobilizing acute myeloid leukemia patients

被引:0
|
作者
Shumilov, E. [1 ]
Novak, U. [2 ,3 ]
Taleghani, Mansouri B. [4 ,5 ]
Bacher, U. [4 ,5 ,6 ]
Pabst, T. [2 ,3 ]
机构
[1] Univ Med Gottingen UMG, Dept Hematol & Med Oncol, Gottingen, Germany
[2] Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland
[3] Bern Univ Hosp, Univ Canc Ctr Inselspital, Ctr Hematooncol, Inselspital, Bern, Switzerland
[4] Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland
[5] Bern Univ Hosp, Cent Hematol Lab, Inselspital, Bern, Switzerland
[6] Bern Univ Hosp, Univ Inst Clin Chem, Ctr Lab Med ZLM, Inselspital, Bern, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P917
引用
收藏
页码:251 / 251
页数:1
相关论文
共 50 条
  • [1] Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients
    Shumilov, Evgenyi
    Novak, Urban
    Jeker, Barbara
    Taleghani, Behrouz Mansouri
    Bacher, Ulrike
    Pabst, Thomas
    HEMASPHERE, 2019, 3 (02):
  • [2] Plerixafor and pegylated filgrastim: a case of safe and effective hematopoietic stem cell mobilization
    M J Fesler
    G Kudva
    P J Petruska
    Bone Marrow Transplantation, 2010, 45 : 1367 - 1368
  • [3] Plerixafor and pegylated filgrastim: a case of safe and effective hematopoietic stem cell mobilization
    Fesler, M. J.
    Kudva, G.
    Petruska, P. J.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1367 - 1368
  • [4] Stem cell mobilization with plerixafor in poorly mobilizing myeloma and lymphoma patients - A single-centre experience and strategies
    Basak, G. W.
    Urbanowska, E.
    Witkowska, M.
    Zdunczyk, D.
    Waszczuk-Gajda, A.
    Skwierawska, K.
    Drozd, J.
    Skibinska, M.
    Glazer, M.
    Madry, K.
    Halaburda, K.
    Torosian, T.
    Krol, M.
    Wiktor-Jedrzejczak, W.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S320 - S321
  • [5] Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients
    Kobold, S.
    Isernhagen, J.
    Huebel, K.
    Kilic, N.
    Bogner, C.
    Frickhofen, N.
    Bokemeyer, C.
    Fiedler, W.
    BONE MARROW TRANSPLANTATION, 2011, 46 (08) : 1053 - 1056
  • [6] Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients
    S Kobold
    J Isernhagen
    K Hübel
    N Kilic
    C Bogner
    N Frickhofen
    C Bokemeyer
    W Fiedler
    Bone Marrow Transplantation, 2011, 46 : 1053 - 1056
  • [7] PLERIXAFOR IS EFFECTIVE AND SAFE FOR STEM CELL MOBILIZATION IN HEAVILY PRETREATED GERM CELL TUMOR PATIENTS
    Kobold, S.
    Isernhagen, J.
    Huebel, K.
    Kilic, N.
    Bogner, C.
    Frickhofen, N.
    Bokemeyer, C.
    Fiedler, W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 658 - 658
  • [8] Plerixafor for Hematopoietic Stem Cell Mobilization in Children With Neuroblastoma
    Naithani, Rahul
    Sachdeva, Mansi
    Rai, Reeta
    Dayal, Nitin
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 (03) : 358 - 359
  • [9] Hematopoietic stem cell mobilization with plerixafor in sickle cell disease
    Hsieh, Matthew M.
    Tisdale, John F.
    HAEMATOLOGICA, 2018, 103 (05) : 749 - 750
  • [10] Hematopoietic stem cell transplantation for acute myeloid leukemia
    Akiyoshi Takami
    International Journal of Hematology, 2018, 107 : 513 - 518